Dr. Catherine Butkus Small, MD

Dr. Small practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Small's NPI, 1881617520, was assigned on July 25, 2006. Dr. Small graduated from New York Medical College in 1977. Dr. Small holds New York license 136538.

Dr. Small's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Small's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Small to 2 more clinical labs and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Small practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Small's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Small is licensed in New York.

CMS data shows 350 Medicare services from Dr. Small across 6 procedure codes in 2024, for 78 Medicare patients. Medicare paid $35,693 for them.

CMS counts 78 Medicare patients who saw Dr. Small in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 4.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Small's median patient age at 62, with 46% women.

In 2024, Dr. Small wrote 83 Medicare Part D claims for 11 patients. 14% of them were for generic drugs. CMS names the drug for 48 of them, across 3 drugs with 11 or more claims each, at $186,682 in total drug cost. In 2023, CMS named 54 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Small for performance year 2024, reported through an alternative payment model (APM). Dr. Small accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Small as offering telehealth.

Dmand AI links 37 papers to Dr. Small, published from 2005 to 2025. 2020 was the busiest year, with 4. The most frequent topics are HIV Infections, Double-Blind Method and Transplant Recipients. Dr. Small has published most often in Clin Infect Dis. Dr. Small's most frequent co-authors are Christine Marie Durand, Sander S. Florman, MD and Dorry Segev, MD.

Dmand AI links Dr. Small to 7 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Acquired Immunodeficiency Syndrome, COVID-19 and Pneumonia, Viral. Johns Hopkins University sponsors the most, 2.

CMS Open Payments shows 8 general payments to Dr. Small from 5 drug and device companies from 2017 to 2024. Speaker and faculty fees make up the largest share, 58% of the total. Partner Therapeutics, Inc. paid the most, $1,357.

Dr. Small graduated from New York Medical College in 1977.